Kedar Ghimire

932 total citations
24 papers, 627 citations indexed

About

Kedar Ghimire is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Kedar Ghimire has authored 24 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Surgery. Recurrent topics in Kedar Ghimire's work include Phagocytosis and Immune Regulation (8 papers), Pancreatic function and diabetes (5 papers) and Advanced Glycation End Products research (3 papers). Kedar Ghimire is often cited by papers focused on Phagocytosis and Immune Regulation (8 papers), Pancreatic function and diabetes (5 papers) and Advanced Glycation End Products research (3 papers). Kedar Ghimire collaborates with scholars based in Australia, United States and Switzerland. Kedar Ghimire's co-authors include Jeffrey S. Isenberg, Adam C. Straub, Natasha M. Rogers, Helene M. Altmann, Curzio Rüegg, Sohel M. Julovi, Jelena Zarić, Žarko Milošević, Nenad Filipović and Nikita Minhas and has published in prestigious journals such as Nature Communications, Scientific Reports and The FASEB Journal.

In The Last Decade

Kedar Ghimire

23 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kedar Ghimire Australia 15 248 124 119 106 63 24 627
Yingying Dong China 14 249 1.0× 96 0.8× 93 0.8× 66 0.6× 86 1.4× 26 678
Miguel Pérez‐Aso United States 18 357 1.4× 84 0.7× 120 1.0× 61 0.6× 37 0.6× 23 826
Anny‐Claude Luissint United States 13 362 1.5× 117 0.9× 207 1.7× 73 0.7× 60 1.0× 22 1.1k
Xiaopeng Tong China 12 239 1.0× 68 0.5× 71 0.6× 56 0.5× 45 0.7× 32 503
Diane Bouïs United States 11 357 1.4× 67 0.5× 139 1.2× 96 0.9× 83 1.3× 15 909
Leslie Todd United States 12 178 0.7× 54 0.4× 165 1.4× 101 1.0× 75 1.2× 14 695
Naoya Suematsu Japan 17 345 1.4× 90 0.7× 114 1.0× 61 0.6× 85 1.3× 60 788
Emily Wilson United States 8 293 1.2× 88 0.7× 98 0.8× 67 0.6× 81 1.3× 13 565
Claire M.F. Potter United Kingdom 12 264 1.1× 50 0.4× 83 0.7× 148 1.4× 71 1.1× 14 640
Federico Sizzano Switzerland 11 311 1.3× 196 1.6× 170 1.4× 82 0.8× 38 0.6× 28 713

Countries citing papers authored by Kedar Ghimire

Since Specialization
Citations

This map shows the geographic impact of Kedar Ghimire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedar Ghimire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedar Ghimire more than expected).

Fields of papers citing papers by Kedar Ghimire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedar Ghimire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedar Ghimire. The network helps show where Kedar Ghimire may publish in the future.

Co-authorship network of co-authors of Kedar Ghimire

This figure shows the co-authorship network connecting the top 25 collaborators of Kedar Ghimire. A scholar is included among the top collaborators of Kedar Ghimire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedar Ghimire. Kedar Ghimire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huaping, Yang Hu, Qi Liang, et al.. (2025). CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma. Translational Oncology. 60. 102484–102484. 2 indexed citations
2.
Coulter, Sally, et al.. (2025). Regulating islet stress responses through CD47 activation. Diabetologia. 68(6). 1279–1297.
3.
Ghimire, Kedar, Jennifer Li, Sohel M. Julovi, et al.. (2023). A metabolic role for CD47 in pancreatic β cell insulin secretion and islet transplant outcomes. Science Translational Medicine. 15(717). eadd2387–eadd2387. 16 indexed citations
5.
Zhang, Juan, Ze Mi, Zhenhu He, et al.. (2022). 4-OI Protects MIN6 Cells from Oxidative Stress Injury by Reducing LDHA-Mediated ROS Generation. Biomolecules. 12(9). 1236–1236. 12 indexed citations
6.
Ghimire, Kedar, et al.. (2021). MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis. Cell Adhesion & Migration. 15(1). 126–139. 14 indexed citations
7.
Zhang, Juan, Lu Cao, Pengfei Rong, et al.. (2021). Benefit of Belatacept in Cord Blood-Derived Regulatory T Cell-Mediated Suppression of Alloimmune Response. Cell Transplantation. 30. 4211104412–4211104412. 2 indexed citations
8.
Rogers, Natasha M. & Kedar Ghimire. (2021). Immunomodulation of Islet Organoids and the Promise of Sustainable Beta Cell Replacement: Has the Challenge Been Met?. Transplantation. 105(3). 466–467. 1 indexed citations
9.
Hameed, Ahmer, Heather Burns, Yi Vee Chew, et al.. (2020). Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform. Scientific Reports. 10(1). 6930–6930. 26 indexed citations
10.
Ghimire, Kedar, Yao Li, Takuto Chiba, et al.. (2020). CD47 Promotes Age-Associated Deterioration in Angiogenesis, Blood Flow and Glucose Homeostasis. Cells. 9(7). 1695–1695. 35 indexed citations
11.
Minhas, Nikita, Daniel N. Meijles, Jennifer Li, et al.. (2020). Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury. Scientific Reports. 10(1). 21968–21968. 10 indexed citations
12.
Julovi, Sohel M., et al.. (2020). Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis. Laboratory Investigation. 100(9). 1184–1196. 27 indexed citations
13.
Evans, Brian C., Kameron V. Kilchrist, Eric A. Dailing, et al.. (2019). An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles. Nature Communications. 10(1). 5012–5012. 68 indexed citations
14.
Ghimire, Kedar, et al.. (2019). CD47 limits autophagy to promote acute kidney injury. The FASEB Journal. 33(11). 12735–12749. 14 indexed citations
15.
Ghimire, Kedar, Jelena Zarić, Jochen Seebach, et al.. (2019). MAGI1 Mediates eNOS Activation and NO Production in Endothelial Cells in Response to Fluid Shear Stress. Cells. 8(5). 388–388. 47 indexed citations
16.
Rogers, Natasha M., Kedar Ghimire, Marı́a J. Calzada, & Jeffrey S. Isenberg. (2017). Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease. Cardiovascular Research. 113(8). 858–868. 26 indexed citations
17.
Ghimire, Kedar, Helene M. Altmann, Adam C. Straub, & Jeffrey S. Isenberg. (2016). Nitric oxide: what’s new to NO?. American Journal of Physiology-Cell Physiology. 312(3). C254–C262. 158 indexed citations
18.
Filipović, Nenad, Kedar Ghimire, Igor Šaveljić, Žarko Milošević, & Curzio Rüegg. (2015). Computational modeling of shear forces and experimental validation of endothelial cell responses in an orbital well shaker system. Computer Methods in Biomechanics & Biomedical Engineering. 19(6). 581–590. 35 indexed citations
19.
Olszewski, Pawel K., Katarzyna J. Radomska, Kedar Ghimire, et al.. (2011). Fto immunoreactivity is widespread in the rodent brain and abundant in feeding-related sites, but the number of Fto-positive cells is not affected by changes in energy balance. Physiology & Behavior. 103(2). 248–253. 18 indexed citations
20.
Palczewska, Małgorzata, Íñigo Casafont, Kedar Ghimire, et al.. (2010). Sumoylation regulates nuclear localization of repressor DREAM. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(5). 1050–1058. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026